About Eli-20 Aurochem Pharmaceuticals
Eli-20 is a phosphodiesterase type 5 (PDE5) inhibitor compound manufactured by Aurochem Pharmaceuticals for in-vitro research applications. This research chemical belongs to the class of selective PDE5 enzyme inhibitors, sharing structural characteristics with established pharmaceutical compounds used in vascular research. Scientists at Stroid UK Shop examine this compound for its potential applications in cardiovascular biology, smooth muscle research, and nitric oxide pathway investigations. The compound demonstrates selective inhibition of PDE5 enzymes in laboratory studies, making it valuable for researchers investigating cyclic guanosine monophosphate (cGMP) signalling pathways.
Laboratory Applications
Research scientists investigate Eli-20 for various preclinical applications including vascular smooth muscle studies, endothelial function research, and nitric oxide-dependent signalling pathway analysis. The compound’s mechanism involves selective PDE5 enzyme inhibition, which prevents the breakdown of cGMP in smooth muscle cells under controlled laboratory conditions. This property makes it particularly useful for cardiovascular research protocols examining vascular reactivity and blood flow regulation mechanisms. Investigators studying pulmonary vascular research and smooth muscle physiology frequently examine PDE5 inhibitors like those found in specialised research compounds for their experimental applications. Research applications extend to studies examining the role of PDE5 in various tissue types and cellular signalling cascades.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Tadalafil-based research chemical |
| Manufacturer | Aurochem Pharmaceuticals |
| Form | Oral research preparation |
| Storage Requirements | Room temperature, dry environment |
| Research Classification | PDE5 inhibitor compound |
| Molecular Target | Phosphodiesterase type 5 enzyme |
Researchers conducting studies with similar compounds often explore selective androgen receptor modulators and peptide research chemicals as complementary research tools in their investigations.
Research Compliance
Eli-20 is manufactured exclusively for in-vitro research applications and laboratory investigations. This research chemical is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain proper laboratory protocols when handling this compound and ensure compliance with institutional research guidelines. All studies should be conducted under appropriate laboratory supervision with proper safety measures in place.
